SUCLG2 and posterior cortical atrophy: Among the known markers, succinyl-coenzyme A (CoA) ligase GDP-forming subunit beta (SUCLG2), a significant player in the lipid metabolism pathway, has emerged as a potential prognostic marker and therapeutic target in PCa (Lin et al., 2020; Hu et al., 2023).